United States· US:42961-222_3857f332-6827-42a6-908f-ce87ed98a5ba
Xpect Triple Antibiotic
A other antibiotics for topical use product containing bacitracin zinc, neomycin sulfate and polymyxin b sulfate, registered in United States by Cintas Corporation. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Bacitracin zinc, neomycin sulfate and polymyxin b sulfate is registered in 4 of 19 countries.
Countries holding a registration under ATC D06AX (other antibiotics for topical use), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Bacitracin zinc, neomycin sulfate and polymyxin b sulfate · ATC D06AX
4 / 19 countries
- Belgiumprice
- Czechiaprice
- Polandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- bacitracin zinc, neomycin sulfate and polymyxin b sulfate
- Manufacturer
- Cintas Corporation
- Country
- United States (US)
- ATC code
- D06AX
- ATC class
- Other antibiotics for topical use
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 4
- ndc114296122201.7 g in 1 PACKAGE (42961-222-01)
- ndc11429612220210 PACKET in 1 BOX (42961-222-02) / .7 g in 1 PACKET
- ndc11429612220320 PACKET in 1 BOX (42961-222-03) / .7 g in 1 PACKET
- ndc114296122204144 PACKET in 1 BOX (42961-222-04) / .7 g in 1 PACKET
Regulatory notes
Same class
Other records under D06AX
Other antibiotics for topical use, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b785c1b0-2097-4fb6-ba1f-64d1717dc6c9 GET /v1/drugs/b785c1b0-2097-4fb6-ba1f-64d1717dc6c9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "89Y4M234ES",
"rxcui": "11417",
"inchikey": null,
"display_name": "BACITRACIN ZINC",
"substance_type": "mixture",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "TOPICAL",
"spl_meta": {
"348e6062-b31e-435e-a153-6aa868b50efa": {
"match": "brand_token",
"title": "XPECT STOPAIN CLINICAL (MENTHOL) GEL [CINTAS CORPORATION]",
"spl_version": "4",
"published_date": "2026-03-16"
}
},
"productid": "42961-222_3857f332-6827-42a6-908f-ce87ed98a5ba",
"productndc": "42961-222",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE",
"shortage_reason": "Bacitracin Ophthalmic Ointment",
"shortage_status": "current",
"proprietary_name": "Xpect Triple Antibiotic",
"active_ingred_unit": "[iU]/g; mg/g; [iU]/g",
"application_number": "M004",
"marketing_category": "OTC MONOGRAPH DRUG",
"nonproprietary_name": "bacitracin zinc, neomycin sulfate and polymyxin b sulfate",
"start_marketing_date": "20220512",
"active_numerator_strength": "400; 5; 5000"
}See everything about bacitracin zinc, neomycin sulfate and polymyxin b sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.